$22,36
-$0,40(-1,75 %)
*Data last updated: 2026-07-11 03:09 (UTC+8)
As of 2026-07-11 03:09, Baxter International Inc. (BAX) is priced at $22,36, with a total market cap of $11,01B, a P/E ratio of -10,92, and a dividend yield of 0,93 %. Today, the stock price fluctuated between $22,24 and $23,00. The current price is 0,53 % above the day's low and 2,78 % below the day's high, with a trading volume of 6,89M. Over the past 52 weeks, BAX has traded between $17,76 to $23,52, and the current price is -4,93 % away from the 52-week high.
BAX Key Stats
Yesterday's Close$22,02
Market Cap$11,01B
Volumen6,89M
P/E Ratio-10,92
Dividend Yield (TTM)0,93 %
Dividend Amount$0,01
Diluted EPS (TTM)2,14
Net Income (FY)-$957,00M
Revenue (FY)$11,24B
Earnings Date2026-07-30
EPS Estimate0,37
Revenue Estimate$2,79B
Shares Outstanding500,05M
Beta (1Y)0.642
Ex-Dividend Date2026-05-29
Dividend Payment Date2026-07-01
About BAX
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic agents, critical care products, and pharmacy compounding services. Nutritional support is provided through its parenteral nutrition therapies and associated products. For surgical procedures, the company develops biological products and medical devices vital for achieving hemostasis, tissue sealing, and preventing adhesions. Additionally, Baxter supplies continuous renal replacement therapies (CRRT) and other organ support solutions, primarily tailored for intensive care units. Beyond direct medical supplies, Baxter provides sophisticated connected care solutions, integrating devices, software, communication systems, and other advanced technologies. This includes a range of patient monitoring and diagnostic technologies designed to aid in the diagnosis, treatment, and management of numerous illnesses and conditions, spanning respiratory therapy, cardiology, vision screening, and physical assessment. The surgical suite benefits from its specialized video technologies, operating tables, lights, pendants, precision positioning tools, and various ancillary accessories. The company also offers contracted services to a multitude of pharmaceutical and biopharmaceutical companies. Baxter's products are utilized across diverse healthcare environments, including hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and for home-based patients under medical supervision. Operating in approximately 100 countries, Baxter distributes its extensive product line through a direct sales force, independent distributors, drug wholesalers, and specialty pharmacies or other alternative site providers. The company also holds a collaborative agreement with Celerity Pharmaceutical, LLC, focused on developing generic injectable pre-mixed medications for acute care and oncolytic molecules. Established in 1931, Baxter International Inc. is headquartered in Deerfield, Illinois.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOAndrew Hider
HeadquartersDeerfield,IL,US
Official Websitehttps://www.baxter.com
Employees (FY)37,50K
Average Revenue (1Y)$299,84K
Net Income per Employee-$25,52K
Baxter International Inc. (BAX) FAQ
What's the stock price of Baxter International Inc. (BAX) today?
x
Baxter International Inc. (BAX) is currently trading at $22,36, with a 24h change of -1,75 %. The 52-week trading range is $17,76–$23,52.
What are the 52-week high and low prices for Baxter International Inc. (BAX)?
x
What is the price-to-earnings (P/E) ratio of Baxter International Inc. (BAX)? What does it indicate?
x
What is the market cap of Baxter International Inc. (BAX)?
x
What is the most recent quarterly earnings per share (EPS) for Baxter International Inc. (BAX)?
x
Should you buy or sell Baxter International Inc. (BAX) now?
x
What factors can affect the stock price of Baxter International Inc. (BAX)?
x
How to buy Baxter International Inc. (BAX) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.